Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site

Table 1

Baseline characteristics of the study population.

	N = 100
Age, mean ± SD (yr)	67.1 ± 11.3
Male sex	65
Current smoker	26
Family history of cardiovascular disease	52
Arterial hypertension	60
Hypercholesterolaemia	49
Diabetes- insulin dependent	11
Diabetes- noninsulin dependent	12
Peripheral artery disease	3
Medication use at admission
Antiplatelet therapy	90
Dual antiplatelet therapy	47
ACE inhibitors or angiotensin-receptor blockers	43
Beta-blockers	80
Calcium channel blockers	27
Statins	82
Cardiac symptoms
Angina	81
Dyspnoea	17
Palpitations	7
Procedure
Coronary angiography	57
Percutaneous coronary intervention	43

Exactly 100 patients were included in analysis. Therefore, for the convenience of the reader, only absolute count is noted, as it is the same as the percentage. ACE = angiotensin-converting enzyme; SD = standard deviation.